Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Honorary Consultant Medical Oncologist
19 Aug 2024 → …
Fingerprint
Dive into the research topics where Sara Valpione is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Controversies in upper GI: liquid biopsies
Pietrantonio, F., Rothwell, D. & Valpione, S., 1 Jan 2024, In: ESMO Open. 9, 1, 102204.Research output: Contribution to journal › Article › peer-review
Open Access -
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Björk, J. R., Bolte, L. A., Maltez Thomas, A., Lee, K. A., Rossi, N., Wind, T. T., Smit, L. M., Armanini, F., Asnicar, F., Blanco-Miguez, A., Board, R., Calbet-Llopart, N., Derosa, L., Dhomen, N., Brooks, K., Harland, M., Harries, M., Lorigan, P., Manghi, P. & Marais, R. & 20 others, , 1 Mar 2024, In: Nature Medicine. 30, 3, p. 785-796 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
MicroRNA-142 regulates gut associated lymphoid tissues and group 3 innate lymphoid cells
Roberts, L. B., Neves, J. F., Lee, D. C. H., Valpione, S., Tachó-Piñot, R., Howard, J. K., Hepworth, M. R. & Lord, G. M., 7 Sept 2024, (E-pub ahead of print) In: Mucosal Immunology.Research output: Contribution to journal › Article › peer-review
Open Access -
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
Larkin, J., Marais, R., Porta, N., Gonzalez de Castro, D., Parsons, L., Messiou, C., Stamp, G., Thompson, L., Edmonds, K., Sarker, S., Banerji, J., Lorigan, P., Evans, T. R. J., Corrie, P., Marshall, E., Middleton, M. R., Nathan, P., Nicholson, S., Ottensmeier, C. & Plummer, R. & 3 others, , 19 Mar 2024, In: Cell reports. Medicine. 5, 3, 101435.Research output: Contribution to journal › Article › peer-review
Open Access -
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
Kennedy, O. J., Glassee, N., Kicinski, M., Blank, C. U., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Boers-Sonderen, M., Giacomo, A. M. D. & van den Eertwegh, A. J. M. & 12 others, , Apr 2024, In: European journal of cancer (Oxford, England : 1990). 201, 113585.Research output: Contribution to journal › Article › peer-review
Prizes
-
-
-
Christie QICA Award Grand Prize
Valpione, S. (Recipient), 2023
Prize: Prize (including medals and awards)
-
ESMO Leaders Generation Programme Recipient
Valpione, S. (Recipient), 2020
Prize: Prize (including medals and awards)
-